Position in SLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,669,808
+$1,368,451 QoQ
Shares Held
243,152
-1.5% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 72 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. SLN ranks #192 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in SLN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,669,808 | 243,152 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,301,357 | 246,937 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,261,678 | 207,513 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,595,213 | 307,363 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,325,351 | 228,509 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $901,029 | 319,514 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,449,767 | 356,071 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,284,616 | 70,661 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,402,314 | 73,806 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,553,428 | 71,918 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,214,961 | 69,946 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $678,688 | 69,113 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $385,715 | 70,130 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $427,837 | 69,006 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,052,341 | 69,006 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $660,452 | 65,815 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $820,671 | 69,255 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,317,992 | 69,368 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,677,507 | 70,218 | Shares | Sole | 2022-02-14 | |
| 2020-12-31 | $2,046 | 93 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||